AR077823A1 - PROCESS TO PREPARE BENZIMIDAZOL COMPOUNDS REPLACED WITH 2-ARILAMINO OR HETEROARILAMINO - Google Patents

PROCESS TO PREPARE BENZIMIDAZOL COMPOUNDS REPLACED WITH 2-ARILAMINO OR HETEROARILAMINO

Info

Publication number
AR077823A1
AR077823A1 ARP100102911A AR077823A1 AR 077823 A1 AR077823 A1 AR 077823A1 AR P100102911 A ARP100102911 A AR P100102911A AR 077823 A1 AR077823 A1 AR 077823A1
Authority
AR
Argentina
Prior art keywords
fluorine atoms
optionally substituted
alkoxy
pyridyl
heteroarilamino
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of AR077823A1 publication Critical patent/AR077823A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los compuestos obtenidos son utiles para terapia. Reivindicacion 1: Un proceso para preparar un compuesto de formula (1) en la que: R1, R2, R3 y R4 son cada uno independientemente H, halogeno, hidroxilo, alquilo C1-6 opcionalmente sustituido con hasta tres átomos de fluor, alcoxi C1-6 opcionalmente sustituido con hasta tres átomos de fluor, (alcoxi C1-6)carbonilo, (alcoxi C1-4)carbonilamido, amino o carboxi; y Ar es fenilo, naftilo, 3-piridilo, 4-piridilo o tienilo, en el que el fenilo y el naftilo están opcionalmente sustituidos independientemente con halogeno, alquilo C1-6 opcionalmente sustituido con hasta tres átomos de fluor, o alcoxi C1-6 opcionalmente sustituido con hasta tres átomos de fluor, y en el que el 3-piridilo, el 4-piridilo y el tienilo están opcionalmente sustituidos independientemente con alquilo C1-C6 opcionalmente sustituido con hasta tres átomos de fluor, o alcoxi C1-6 opcionalmente sustituido con hasta tres átomos de fluor; o su sal de adicion de ácidos; que comprende hacer reaccionar un compuesto de formula (2) en la que R1, R2, R3 y R4 son como se definio anteriormente, con un compuesto de formula: Ar-NH2 o su sal de adicion de ácidos, en la que Ar es como se definio anteriormente, opcionalmente en presencia de una base adecuada.The compounds obtained are useful for therapy. Claim 1: A process for preparing a compound of formula (1) in which: R1, R2, R3 and R4 are each independently H, halogen, hydroxyl, C1-6 alkyl optionally substituted with up to three fluorine atoms, C1 alkoxy -6 optionally substituted with up to three fluorine atoms, (C1-6 alkoxy) carbonyl, (C1-4 alkoxy) carbonylamide, amino or carboxy; and Ar is phenyl, naphthyl, 3-pyridyl, 4-pyridyl or thienyl, in which phenyl and naphthyl are optionally independently substituted with halogen, C1-6 alkyl optionally substituted with up to three fluorine atoms, or C1-6 alkoxy optionally substituted with up to three fluorine atoms, and in which 3-pyridyl, 4-pyridyl and thienyl are optionally independently substituted with C1-C6 alkyl optionally substituted with up to three fluorine atoms, or optionally substituted C1-6 alkoxy with up to three fluorine atoms; or its acid addition salt; which comprises reacting a compound of formula (2) in which R1, R2, R3 and R4 are as defined above, with a compound of formula: Ar-NH2 or its acid addition salt, in which Ar is as defined above, optionally in the presence of a suitable base.

ARP100102911 2009-08-11 2010-08-09 PROCESS TO PREPARE BENZIMIDAZOL COMPOUNDS REPLACED WITH 2-ARILAMINO OR HETEROARILAMINO AR077823A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23293209P 2009-08-11 2009-08-11

Publications (1)

Publication Number Publication Date
AR077823A1 true AR077823A1 (en) 2011-09-28

Family

ID=42752011

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100102911 AR077823A1 (en) 2009-08-11 2010-08-09 PROCESS TO PREPARE BENZIMIDAZOL COMPOUNDS REPLACED WITH 2-ARILAMINO OR HETEROARILAMINO

Country Status (3)

Country Link
AR (1) AR077823A1 (en)
TW (1) TW201111350A (en)
WO (1) WO2011019781A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230035446A (en) * 2014-06-27 2023-03-13 노그라 파마 리미티드 Aryl receptor modulators and methods of making and using the same
EP3015469B1 (en) 2014-10-30 2018-12-19 Idemitsu Kosan Co., Ltd. 5-(benzimidazol-2-yl)benzimidazo[1,2-a]benzimidazoles for electronic applications
KR101850282B1 (en) * 2014-11-26 2018-05-31 한국과학기술연구원 Heteroarylamine derivatives as protein kinase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049333B2 (en) 2002-06-04 2006-05-23 Sanofi-Aventis Deutschland Gmbh Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
EP1711485B1 (en) * 2003-12-18 2009-05-13 Tibotec Pharmaceuticals Ltd. Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication

Also Published As

Publication number Publication date
TW201111350A (en) 2011-04-01
WO2011019781A1 (en) 2011-02-17

Similar Documents

Publication Publication Date Title
CY1119049T1 (en) Substituted Pyrrolidine-2-Carboxamides
PE20141380A1 (en) IMIDAZOPYRIDAZINES AS KINASE INHIBITORS AKT
EA201390934A1 (en) COMPOSITIONS AND METHODS OF FXR MODULATION
CY1116958T1 (en) Substituted triazolopyridines and their use as TKP inhibitors
CY1116885T1 (en) Substituted cyclohexylmethyl derivatives
AR061924A1 (en) PROCESS TO ELABORATE 2- AMINO -5 - HALOBENZAMIDS 3- REPLACED
AR095347A1 (en) ORGANIC COMPOUNDS
AR070828A1 (en) DERIVATIVES OF AZETIDINE AND CYCLLOBUTANE AS JAK INHIBITORS
PE20140192A1 (en) BENZHIMIDAZOLE DERIVATIVES AS KINASE PI3 INHIBITORS
MY165730A (en) Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
EA201700230A1 (en) DETERMINED AMINOPYRIDINES, COMPOSITIONS ON THEIR BASIS AND METHODS OF THEIR APPLICATION
PH12015501585A1 (en) Manufacturing process for pyrimidine derivatives
AR083873A1 (en) AMINO-PHENYL-PENTANOIC ACID DERIVATIVES REPLACED AS NEP INHIBITORS
IN2014MN01897A (en)
PE20160523A1 (en) DERIVATIVES OF ARYL OR HETEROARYL AS INHIBITORS OF SMALL MOLECULES OF FIBROSIS
PE20121509A1 (en) TRIAZOLOPYRIDINE COMPOUNDS AS MPS-1 KINASE INHIBITORS
AR083578A1 (en) INHIBITORS OF N / N-LACTAMA ACETIL-CoA CARBOXYLASE
RS54189B1 (en) Methods of using alk inhibitors
MX2014006992A (en) Malonic acid di-salts and a method for preparing malonyl dihalides.
EA201300423A1 (en) CRYSTALLINE CONJUGATE NALOXOL-PEG
MX350862B (en) Piperidinyl naphthylacetic acids.
NZ601805A (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
MX337320B (en) Halogenated analogues of anti-fibrotic agents.
PE20091087A1 (en) COMPOUNDS DERIVED FROM 6-PHENYL-1H-IMIDAZO [4,5-c] PYRIDINE-4-CARBONITRILE AS INHIBITORS OF CATEPSIN S AND / OR CATEPSIN K
AR077823A1 (en) PROCESS TO PREPARE BENZIMIDAZOL COMPOUNDS REPLACED WITH 2-ARILAMINO OR HETEROARILAMINO

Legal Events

Date Code Title Description
FB Suspension of granting procedure